Clinical trialNCT04629560CompletedEarly phase 1Interventional

Miracle Fruit Powder for the Treatment of Taste Alterations Secondary to Chemotherapy

SponsorMt. Sinai Medical Center, MiamiEnrollment48DysgeusiaTaste, Altered

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Purpose and Objective: Compare the incidence of taste alteration in treatment vs. control arms and Compare weight loss in treatment vs. control arms

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Mike Cusnir, MD
Mount Sinai Medical Center of Florida
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Miracle Fruit

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 18 Aug 2008
Primary completion: 20 Jun 2011
Completion: 20 Jun 2011
Last update posted: 16 Nov 2020
Registered enrollment: 48
Registry id: NCT04629560

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.